Biotage AB (BIOT) Stock Statistics & Valuation Metrics

Biotage AB has a market cap or net worth of $11.40B. The enterprise value is ―.

Biotage AB has 80,049,270 shares outstanding. The number of shares has decreased by -2.65% in one year.

Biotage AB’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 7.28%.

The current PE Ratio of Biotage AB is 45.31. Biotage AB’s PEG ratio is -4.35.

In the last 12 months, Biotage AB had revenue of 2.06B and earned 284.00M in profits. Earnings per share was 3.55.

In the last 12 months, operating cash flow was 348.00M and capital expenditures -160.00M, giving a free cash flow of 188.00M billion.

Biotage AB pays an annual dividend of kr1.649, resulting in a dividend yield of 1.04%

Biotage AB upcoming earnings date is Jul 16, 2025, TBA Not Confirmed.

Biotage AB as a current ratio of 2.33, with Debt / Equity ratio of 6.19%

In the past 12 months, Biotage AB has paid 44.00M in taxes.

Biotage AB EV to EBITDA ratio is 22.33, with an EV/FCF ratio of 51.99.

Biotage AB has $420.00M in cash and marketable securities with kr238.00M in debt, giving a net cash position of -$182.00M billion.

Gross margin is 62.67%, with operating margin of 18.63%, and net profit margin of 13.81%.

The average price target for Biotage AB is $143.02, which is 11.43% higher than the current price. The consensus rating is Hold